Clinical Trial Update: TKI258 for Metastatic Inflammatory Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TKI258 in metastatic inflammatory breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• TKI258

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-02